|
Main
Portfolio Index > 2007 Genetic Index > Molecular Pharma
2007 NIDA Genetics Portfolio (Molecular Pharma)
2007 NIDA Molecular Pharma Portfolio Listing A - Z
| |
|
 |
| ABOOD, MARY E |
Molecular Characterization of GPR35 and GPR55, Putative Cannabinoid Receptors |
| |
1R01DA023204-01 |
| |
|
| ADLER, MARTIN W |
Center on Intersystem Regulation Drugs of Abuse |
| |
1F31DA021968-01A1 |
| |
|
| ANAGNOSTARAS, STEPHAN G |
Molecular Cognition of Addiction |
| |
1R01DA020041-01A2 |
| |
|
| |
|
| ANAND, RENE |
Modulation of Nicotinic Receptors by Cytosolic Proteins |
| |
5R01DA019675-03 |
| |
|
| ANAND, RENE |
Proteomics of Nicotinic Receptor Complexes |
| |
5R21DA020156-02NCE |
| |
|
| ANASTASIO, NOELLE C |
Role of NMDAR Regulation in Phencyclidine-Induced Neurotoxicity |
| |
5F31DA022824-02 |
| |
|
| ANDERSON, GEORGE M |
Neuroendocrine, Pharmacology, and Genetics Core Resource |
| |
1PL1DA024860-01 |
| |
|
| ANDRZEJEWSKI, MATTHEW E. |
|
| |
5R01DA004788-22 |
| |
|
| ANG, ROSALIND L |
Mechanisms of hallucinogen specific neuronal response |
| |
5F31DA020308-01NCE |

|
| |
|
 |
| BARKER, ERIC L |
Psychostimulant Recognition by Serotonin Transporters |
| |
5R01DA018682-06 |
| |
|
| BARRES, BEN A |
Role of Glia in the Formation of Functional Synapses |
| |
5R01DA015043-07 |
| |
|
| BARTLETT, SELENA E. |
Targeting Opioid Receptor Heterodimers for Pain Treatment |
| |
1R41DA023323-01 |
| |
|
| BAYER, BARBARA M |
Neurobiology of Drug Abuse |
| |
5T32DA007291-13 |
| |
|
| BELOUSOV, ANDREI B |
CHOLINERGIC REGULATION IN THE HYPOTHALAMUS |
| |
5R01DA015088-04 |
| |
|
| BELOUSOV, ANDREI B |
CHOLINERGIC REGULATION IN THE HYPOTHALAMUS |
| |
7R01DA015088-05 |
| |
|
| BENAVIDES, DAVID R |
MINORITY PREDOCTORAL FELLOWSHIP PROGRAM |
| |
5F31DA020199-02 |
| |
|
| BERGLIND, WILLIAM J |
Cortico-striatal BDNF and cocaine withdrawal and relapse |
| |
3F31DA018500-01A2S1 |
| |
|
| BERNARDI, RICK E |
Amygdala D1 Receptor Modulation of Cocaine-Mediated Memories |
| |
1F31DA022844-01 |
| |
|
| BIDLACK, JEAN M |
Pharmacology of Drug Abuse |
| |
2T32DA007232-21A1 |
| |
|
| BLAKELY, RANDY D |
Regulation of Serotonin Transporters |
| |
3R01DA007390-17S1 |
| |
|
| BLAKELY, RANDY D |
Regulation of Serotonin Transporters |
| |
5R01DA007390-17 |
| |
|
| BOUHAMDAN, MOHAMAD |
RGS9-2 Protein: Novel Partners and Functional Roles |
| |
5R21DA021404-02 |
| |
|
| BRUCHAS, MICHAEL R |
Kappa-opioid mediated stress response |
| |
5F32DA020430-03 |

|
| |
|
 |
| CADWALLADER, AMY B |
Mechanism of Action of Anabolic-Androgenic Steroids |
| |
1F31DA022809-01A1 |
| |
|
| CARROLL, FRANK I |
Selective Opioid Antagonist as Medication for Drug Abuse |
| |
5R01DA009045-13 |
| |
|
| CASTER, JOSEPH M |
Adolescent Vulnerbility to Neuroplastic Changes Induced by High Dose Cocaine. |
| |
1F31DA022813-01 |
| |
|
| CHAVKIN, CHARLES |
Regulation of Opioid Signaling by Tyr-Phosphorylation |
| |
5R37DA011672-09 |
| |
|
| CHAVKIN, CHARLES |
TRAINING IN THE MOLECULAR PHARMACOLOGY OF ABUSED DRUGS |
| |
5T32DA007278-14 |
| |
|
| CHILDERS, STEVEN R |
Neuroscience of Drug Abuse Training Program |
| |
2T32DA007246-16A1 |
| |
|
| CICERO, THEODORE J |
Biomedical Research Training in Drug Abuse |
| |
2T32DA007261-16A1 |
| |
|
| CLARK, DAVID J |
Genetic Determinants of Opioid-Induced Hyperalgesia |
| |
1R01DA021332-01A2 |
| |
|
| COLES, LISA D |
Changes in Brain and Placental Distribution During Pregnancy |
| |
5F31DA022816-02 |
| |
|
| CONRAD, KELLY L |
Cocaine Craving and Receptor Trafficking |
| |
5F31DA021448-02 |
| |
|
| CUNNINGHAM, KATHRYN A |
Translational Center on Serotonin and Stimulant Addiction |
| |
1P20DA024157-01 |

|
| |
|
 |

|
| |
|
 |

|
| |
|
 |

|
| |
|
 |

|
| |
|
 |
| HALL, EDWARD D |
Therapeutic Strategies for Neurodegeneration Training Grant |
| |
5T32DA022738-02 |
| |
|
| HARDT, TRICIA A |
Cannabinoid Signaling: Role of Cannabinoid Receptor Interacting Protein (CRIP1a) |
| |
1F31DA023747-01 |
| |
|
| HEBERLEIN, ULRIKE A |
Molecular Genetics of Psychostimulant Action |
| |
5R01DA019573-02 |
| |
|
| HEINEMANN, STEPHEN F |
Role of Brain Nicotinic Receptors in Addiction Behaviors |
| |
5R01DA018247-02 |
| |
|
| HENRY, LOREN K |
Integration of Computational and Biological Analysis of Serotonin Transporters |
| |
1K01DA022378-01A1 |
| |
|
| HOHMANN, ANDREA G |
ENDOCANNABINOID ANALGESIA: AN IN VIVO GENE TRANSFER - LIPIDOMICS APPROACH |
| |
5R21DA022478-02 |
| |
|
| HOLMES, KING K |
University of Washington Center for AIDS Research |
| |
5P30AI027757-20 |
| |
|
| HOOK, VIVIAN Y |
Biosynthesis of Enkephalin Opioid Peptides |
| |
5R01DA004271-22 |
| |
|
| HOXIE, JAMES A |
Center For AIDS Research |
| |
5P30AI045008-09 |
| |
|
| HRUBY, VICTOR J |
New Modalities for Treatment of Pain and Drug Abuse |
| |
5P01DA006284-17 |
| |
|
| HRUBY, VICTOR J |
NOVEL NON-PEPTIDE OPIOID LIGANDS FOR PAIN |
| |
5R01DA013449-08 |
| |
|
| HUBERT, GEORGE W |
Anatomy and Activation of Nucleus Accumbens CART Neurons |
| |
5F32DA021056-01NCE |
| |
|
| HURD, YASMIN L |
Dynorphin /kappa mesolimbic system in heroin abuse |
| |
5R01DA015446-05 |

|
| |
|
 |

|
| |
|
 |

|
| |
|
 |

|
| |
|
 |
| LANDAU, EMMANUEL M |
Translational control of LTP |
| |
5R01DA015863-05 |
| |
|
| LANDRY, CHARLES F |
Nicotine and Gene Expression in Adolescent Brain |
| |
5R01DA019153-04 |
| |
|
| LARIVIERE, WILLIAM R |
GENETICS OF NEUROPATHIC & INFLAMMATORY HYPERSENSITIVITY |
| |
1R01DA021198-01A2 |
| |
|
| LAW, PING-YEE |
G Proteins and Opiate Receptor Functions |
| |
5K05DA000513-07 |
| |
|
| LAW, PING-YEE |
G PROTEINS AND OPIOID RECEPTOR FUNCTIONS |
| |
5R01DA007339-17 |
| |
|
| LESTER, ROBIN A |
Subunit-specific Regulation/Neuronal Nicotinic Receptors |
| |
5R01DA011940-08 |
| |
|
| LI, MING D |
Deciphering genes and pathways in nicotine dependence |
| |
3R01DA013783-09S1 |
| |
|
| LI, MING D |
Deciphering genes and pathways in nicotine dependence |
| |
5R01DA013783-09 |
| |
|
| LICHTMAN, ARON H |
Endocannabinoid modulation of memory |
| |
5R01DA015683-04 |
| |
|
| LINDBERG, IRIS |
Opioid Peptide Synthesizing Enzymes |
| |
5R01DA005084-20 |
| |
|
| LINDBERG, IRIS |
Opioid Peptide Synthesizing Enzymes |
| |
7R01DA005084-21 |
| |
|
| LIU, CHRISTINA H |
MR Assessment of Altered Cerebral Gene Expression after Amphetamine Exposure |
| |
1R21DA024235-01 |
| |
|
| LOH, HORACE H |
Center on Molecular and Cell Biology of Drug Abuse |
| |
5P50DA011806-10 |
| |
|
| LOH, HORACE H |
Neurochemical Basis of Opiate Addiction |
| |
5R01DA000564-35 |
| |
|
| LONDON, EDYTHE D |
Response Inhibition and Dopamine Neurotransmission (RI) (4 of 8) |
| |
1RL1DA024853-01 |
| |
|
| LOW, WALTER C |
Translational Research in Neurobiolgy of Disease Training Program |
| |
5T32DA022616-02 |
| |
|
| LOZADA, ADRIAN F |
Nicotinic Regulation of Hippocampal Synapse Formation |
| |
1F32DA023748-01 |
| |
|
| LUKAS, RONALD J |
Molecular Bases for Effects of Nicotine |
| |
5R01DA015389-05 |
| |
|
| LULL, MELINDA E |
Proteomic Adaptations of Abstinence-Induced Behavioral Sensitization to Cocaine |
| |
1F31DA022819-01 |

|
| |
|
 |
| MAHATA, SUSHIL K |
Chromaffin Cell physiology: Novel molecular approaches |
| |
5R01DA011311-08 |
| |
|
| MARKOWITZ, JOHN S |
Drug Transporters and the Disposition of ADHD Therapeutic Agents |
| |
1R01DA022475-01A1 |
| |
|
| MARTEMYANOV, KIRILL A. |
Molecular Basis of RGS Protein Function in the Striatum |
| |
1R01DA021743-01A2 |
| |
|
| MARTIN, BILLY R |
CENTER FOR DRUG ABUSE RESEARCH |
| |
2P50DA005274-19A1 |
| |
|
| MASSEY, KERRI A |
Nicotinic and GABAergic Interactions in Hippocampal Development |
| |
1F31DA020980-01A1 |
| |
|
| MCGINTY, JACQUELINE F |
Drug Abuse Training Program |
| |
2T32DA007288-16 |
| |
|
| MCKEE, BRENDA L |
Homer Upregulation During Instrumental Learning in the Dorsomedial Striatum |
| |
1F32DA023761-01 |
| |
|
| MERMELSTEIN, PAUL G |
NFAT-mediated gene expression and striatal plasticity |
| |
5R01DA017881-03 |
| |
|
| MEUCCI, OLIMPIA |
Role of chemokine receptors in neuronal survival |
| |
2R01DA015014-06A2 |
| |
|
| MOLITOR, THOMAS W |
TRAINING IN NEUROIMMUNE/NEUROBEHAVIOR ADDICTION RESEARCH |
| |
2T32DA007097-26A1 |
| |
|
| MORON-CONCEPCION, JOSE A |
PSD protein expression in extinction of morphine-dependent conditioned behavior |
| |
1R03DA023454-01 |

|
| |
|
 |

|
| |
|
 |

|
| |
|
 |

|
| |
|
| |

|
| |
|
 |
| RAEHAL, KIRSTEN M |
Opioid-Induced Somatic Effects in Betaarrestin2-KO Mice |
| |
5F31DA021952-02 |
| |
|
| RAYPORT, STEPHEN G |
Psychostimulant sensitization at the synaptic level |
| |
5K02DA000356-09 |
| |
|
| REGGIO, PATRICIA H |
Molecular Determinants for Cannabinoid Activity |
| |
5R01DA003934-21 |
| |
|
| REITH, MAARTEN E |
The dopamine transporter and ions, substrates, blockers |
| |
5R01DA013261-08 |
| |
|
| REITH, MAARTEN E |
Dopamine Transporters: Mechanisms of Ligand Interaction |
| |
5R01DA019676-02 |
| |
|
| RESSLER, KERRY J |
Molecular Regulation of GABA(A) Receptor Function in Amygdala |
| |
5R01DA019624-02 |
| |
|
| REYNOLDS, JESSICA L |
Mechanisms of Cocaine-Induced HIV-1 infection in NHA |
| |
5F32DA021535-02 |
| |
|
| RIEGER, JAYSON MICHAEL |
Adenosine A2A receptor antagonists for the treatment of cocaine addiction |
| |
1R43DA022110-01 |
| |
|
| ROGERS, JASON L |
Effects of Methamphetamine on Relapse, Working Memory and Serotonin Transporters. |
| |
1F32DA022842-01A1 |
| |
|
| ROGGE, GEORGE A |
Regulation of the CART gene by promoter cis-elements |
| |
5F31DA021970-02 |
| |
|
| ROTH, MICHAEL D |
EFFECTS OF MARIJUANA ON HIV AND VIRAL IMMUNITY |
| |
5R01DA003018-25 |
| |
|
| ROY, SABITA |
Role of Mu Opioid Receptor in Immune Function |
| |
2K02DA015349-06 |
| |
|
| RUDNICK, GARY W |
Ion and Biogenic Amine Transport Mechanism |
| |
2R01DA007259-14A1 |
| |
|
| RUDNICK, GARY W |
Neurotransmitter Transport |
| |
5R01DA008213-13 |

|
| |
|
 |
| SANDERS-BUSH, ELAINE |
Hallucinogens and Serotonin Signal Transduction |
| |
5R01DA005181-18 |
| |
|
| SAYLOR, ALICIA J |
Amphetamine and BDNF-mediated gene expression |
| |
5F31DA020238-02 |
| |
|
| SCHILTZ, CRAIG A |
Molecular Basis of Addiction: Conditioning and Relapse |
| |
5F30DA016503-05 |
| |
|
| SEYBOLD, VIRGINIA S |
Neuroscience Training in Drug Abuse Research |
| |
2T32DA007234-21 |
| |
|
| SHARP, BURT M |
Interaction Between Nicotine and Stress |
| |
5R01DA003977-23 |
| |
|
| SIGGINS, GEORGE R |
Morphine Like Brain Peptides-Cellular Neurobiology |
| |
5R01DA003665-24 |
| |
|
| SIMEN, ARTHUR A |
Epigenetic Factors in Stress-enhanced Acquisition of Cocaine Self-Administration. |
| |
5R03DA022251-02 |
| |
|
| SIMON, ERIC J |
Effects of morphine and analogues on cell metabolism |
| |
3R01DA000017-40S2 |
| |
|
| SMITH, JAMES E |
Neurobiological Parameters of Cocaine Reinforcement |
| |
5R01DA003628-20 |
| |
|
| SMITH, SHERYL S |
Steroids and GABA: Physiology of Receptor Subunit Change |
| |
5R01DA009618-11 |
| |
|
| SNYDER, SOLOMON H |
Drug Abuse Research Center |
| |
2P50DA000266-36 |
| |
|
| SODERSTROM, KENNETH M |
Cannabinoid-Altered Vocal Development |
| |
1R01DA020109-01A2 |
| |
|
| SORKIN, ALEXANDER D |
Dopamine Transporter Regulation by Endocytosis |
| |
5R01DA014204-06 |
| |
|
| STELLA, NEPHI |
Genetics of endocannabinoid biosynthesis and inactivation |
| |
5R21DA021389-02 |
| |
|
| STELLA, NEPHI |
Novel Monoacylglycerol Lipase |
| |
5R21DA022469-02 |
| |
|
| STEVENS, CRAIG W |
Functional evolution of opioid receptors |
| |
2R15DA012448-05A1 |
| |
|
| STITZEL, JERRY A |
Circadian Variations in Nicotine Sensitivity in Mice |
| |
1R21DA022462-01A1 |
| |
|
| STOWERS, RONALD STEVEN |
Genetic Dissection of Synaptic Transmission |
| |
5K01DA019458-03 |
| |
|
| SULZER, DAVID L |
Presynaptic Mechanisms in Dopamine Neurotransmission |
| |
2R01DA007418-14 |
| |
|
| SURRATT, CHRISTOPHER K |
Monoamine Transporter Structure-Function Studies |
| |
2R15DA016604-03A1 |

|
| |
|
 |
|
| |
|
| |
|
 |
No Names at this time.

|
| |
|
 |

|
| |
|
 |
| WALKER, BRUCE D |
Harvard University Center for AIDS Research |
| |
5P30AI060354-04 |
| |
|
| WANG, JIA B |
MOR PHosphorylation in Opiod Tolerance and Dependence |
| |
5K02DA018722-03 |
| |
|
| WASSUM, KATE M |
Opioid and Glutamate Modulation of Reward Value During Goal-Directed Behavior |
| |
1F31DA023774-01 |
| |
|
| WEI, LI-NA L |
Studies of the Mouse Kappa Opioid Receptor Gene |
| |
2K02DA013926-06 |
| |
|
| WEI, LI-NA L |
Studies of Mouse Kappa Opioid Receptor Gene Regulation |
| |
2R01DA011190-11A1 |
| |
|
| WEINSHENKER, DAVID |
Mechanism of Disulfiram-Induced Cocaine Abstinence |
| |
5R01DA017963-02 |
| |
|
| WEINSTEIN, HAREL |
Hallucinogens and 5-HT Receptors: Mechanisms and Effects |
| |
2P01DA012923-06A1 |
| |
|
| WEINSTEIN, HAREL |
Structure and Function of Neurotransmitter Transporters |
| |
5P01DA012408-09 |
| |
|
| WHISTLER, JENNIFER L |
Role of opioid receptor trafficking in tolerance and dependence |
| |
1R01DA019958-01A2 |
| |
|
| WHISTLER, JENNIFER L |
G Protein Coupled Receptor Trafficking and Opiate Drugs |
| |
5R01DA015232-05 |
| |
|
| WHITEAKER, PAUL |
Alpha-Conotoxin MII: A Selective Nicotinic Receptor Probe |
| |
2R01DA012242-09 |
| |
|
| WINZER-SERHAN, URSULA H |
Nicotinic Modulation of Hippocampal Development |
| |
5R01DA016487-04 |
| |
|
| WOLF, MARINA E |
Glutamate and psychostimulant-induced neuroadaptations |
| |
5K02DA000453-08 |
| |
|
| WOLF, MARINA E |
Glutamate Transmission and Behavioral Sensitization |
| |
5R01DA009621-11 |
| |
|
| WOLF, MARINA E |
Dopamine and Glutamate Receptor Interactions |
| |
5R37DA015835-05 |
| |
|
| WOODS, JAMES H |
Development of Esterases for the Treatment of Cocaine Overdose and Abuse |
| |
5R01DA021416-02 |

|
| |
|
 |

|
| |
|
 |

|
| |
|
 |

|
| |
Return to top |
|
NIDA Genetics Programs
Resources for Genetics, Cell Biology, and Neuroscience
|